Biosimilar Launch Hospira recently launched a biosimilar version of infliximab, branded as Inflectra, to compete in the autoimmune diseases market against the originator product, Remicade, presenting a sales opportunity for expanding market share.

Product Partnership The partnership between Hospira and Smith Medical, LLC to market and promote infusion pumps opens avenues for cross-selling opportunities and expanding product reach in the healthcare industry.

New Product Launch Hospira's introduction of the LifeShield Supercath 5 safety I.V. Catheters in the U.S. provides a sales opportunity to cater to the demand for advanced infusion technology and enhance the company's product portfolio.

Innovative Product Line With the launch of the VISIV line of PVC/DEHP-free IV bags, Hospira has tapped into the sustainability trend and can leverage this eco-friendly product line as a sales proposition to environmentally conscious healthcare facilities.

Quality Assurance Challenges Despite recent quality assurance and regulatory issues leading to office and plant closures, Hospira's commitment to addressing these challenges could present an opportunity for sales by demonstrating dedication to product safety and compliance.